TY - JOUR
T1 - Udredning og behandling af angst og depression hos patienter med KOL
AU - Fogh-Andersen, Ida Stisen
AU - Farver-Vestergaard, Ingeborg
AU - Pedersen, Christian Møller
AU - Tehrani, Elisabeth Shirin
AU - Løkke Ottesen, Anders
PY - 2022/1/10
Y1 - 2022/1/10
N2 - An estimated 33% of patients with COPD have co-morbidities in terms of anxiety and/or depression (A&D). A large proportion of these patients are not diagnosed, mainly because some of the core symptoms of A&D can be misinterpreted as being caused by COPD. Untreated A&D in patients with COPD can have a negative impact on several parameters e.g. dyspnoea and mortality. On this basis, this review argues, that special focus in primary care and hospitals on diagnosing and treating A&D in patients with COPD using anti-depressants or cognitive therapy can reduce symptom burden and significantly improve quality of life.
AB - An estimated 33% of patients with COPD have co-morbidities in terms of anxiety and/or depression (A&D). A large proportion of these patients are not diagnosed, mainly because some of the core symptoms of A&D can be misinterpreted as being caused by COPD. Untreated A&D in patients with COPD can have a negative impact on several parameters e.g. dyspnoea and mortality. On this basis, this review argues, that special focus in primary care and hospitals on diagnosing and treating A&D in patients with COPD using anti-depressants or cognitive therapy can reduce symptom burden and significantly improve quality of life.
KW - Anxiety Disorders/diagnosis
KW - Anxiety/diagnosis
KW - Depression/diagnosis
KW - Humans
KW - Pulmonary Disease, Chronic Obstructive/complications
KW - Quality of Life
M3 - Tidsskriftartikel
C2 - 33491627
SN - 0041-5782
VL - 184
JO - Ugeskrift for Læger
JF - Ugeskrift for Læger
IS - 1
M1 - V09200679
ER -